Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

APRI enters the St. Petersburg market

8/19/24 APRI

Yaroslavnefteorgsintez reported for 6 months of 2024 by IFRS

8/19/24 JNOS

Segezha exits JV with Rossium

8/19/24 SGZH

Magnit decided to start developing by franchising

8/19/24 MGNT

T-Bank prepares an offer to Rosbank's minority shareholders

8/19/24 ROSB

T-Bank received a 99.4% stake in Rosbank

8/19/24 T

Board of Directors of TNS Energy Mari El recommended dividends

8/19/24 MISB

Delimobile reported for 6 months of 2024 by IFRS

8/19/24 DELI

Diasoft reported for 3 months of fiscal year 2024

8/19/24 DIAS

MD Medical entered Lipetsk

8/19/24 MDMG